Success Metrics

Clinical Success Rate
86.2%

Based on 25 completed trials

Completion Rate
86%(25/29)
Active Trials
21(36%)
Results Posted
16%(4 trials)
Terminated
4(7%)

Phase Distribution

Ph phase_2
4
7%
Ph phase_1
2
3%
Ph phase_3
1
2%
Ph not_applicable
21
36%

Phase Distribution

2

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution28 total trials
Phase 1Safety & dosage
2(7.1%)
Phase 2Efficacy & side effects
4(14.3%)
Phase 3Large-scale testing
1(3.6%)
N/ANon-phased studies
21(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

86.2%

25 of 29 finished

Non-Completion Rate

13.8%

4 ended early

Currently Active

21

trials recruiting

Total Trials

59

all time

Status Distribution
Active(23)
Completed(25)
Terminated(4)
Other(7)

Detailed Status

Completed25
Recruiting18
unknown7
Terminated4
Active, not recruiting3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
59
Active
21
Success Rate
86.2%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (7.1%)
Phase 24 (14.3%)
Phase 31 (3.6%)
N/A21 (75.0%)

Trials by Status

not_yet_recruiting12%
terminated47%
active_not_recruiting35%
completed2542%
enrolling_by_invitation12%
recruiting1831%
unknown712%

Recent Activity

Clinical Trials (59)

Showing 20 of 59 trialsScroll for more
NCT00980460Phase 3

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

Active Not Recruiting
NCT05087550

Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation

Completed
NCT06125769Not Applicable

LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA)

Recruiting
NCT06169592

Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation

Recruiting
NCT07301853

Longitudinal Follow-up and Health-Related Outcomes in Liver Transplant Recipients and Living Donors

Recruiting
NCT01756794Not Applicable

Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical Treatment

Completed
NCT06922669Not Applicable

Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia

Recruiting
NCT04378023

Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Hilar Cholangiocarcinoma. A Prospective Multicenter Study.

Recruiting
NCT05248581

Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases

Recruiting
NCT05339984Not Applicable

Hepatic and Systemic Hemodynamic Modeling During Liver Surgery

Recruiting
NCT06799468

Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver Transplantation

Completed
NCT05475613Phase 2

Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation

Recruiting
NCT04898504Phase 2

HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden.

Active Not Recruiting
NCT04195503Not Applicable

Liver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma

Enrolling By Invitation
NCT06626724

A Retrospective Cohort Study on Predicting Delayed Graft Function in Liver Transplant Patients with Hepatocellular Carcinoma: a Nomogram and Machine Learning Approaches.

Completed
NCT05398380Not Applicable

Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research

Recruiting
NCT06535217

Explainable Machine Learning for the Assessment of Donor Grafts in Liver Transplantation

Completed
NCT06382740

Selection Protocol for Liver Transplantation in Patients Aged Over 70 Years

Recruiting
NCT04865471Not Applicable

Resection And Partial Liver Segmental Transplantation With Delayed Total Hepatectomy

Recruiting
NCT02597348Not Applicable

Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy

Active Not Recruiting

Drug Details

Intervention Type
PROCEDURE
Total Trials
59